|
1
|
Han J, Fujisawa T, Husain SR and Puri RK:
Identification and characterization of cancer stem cells in human
head and neck squamous cell carcinoma. BMC Cancer. 14:1732014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Barreyro L, Will B, Bartholdy B, Zhou L,
Todorova TI, Stanley RF, Ben-Neriah S, Montagna C, Parekh S,
Pellagatti A, et al: Overexpression of IL-1 receptor accessory
protein in stem and progenitor cells and outcome correlation in AML
and MDS. Blood. 120:1290–1298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hwang-Verslues WW, Kuo WH, Chang PH, Pan
CC, Wang HH, Tsai ST, Jeng YM, Shew JY, Kung JT, Chen CH, et al:
Multiple lineages of human breast cancer stem/progenitor cells
identified by profiling with stem cell markers. PLoS One.
4:e83772009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Haraguchi N, Ohkuma M, Sakashita H,
Matsuzaki S, Tanaka F, Mimori K, Kamohara Y, Inoue H and Mori M:
CD133+CD44+ population efficiently enriches
colon cancer initiating cells. Ann Surg Oncol. 15:2927–2933. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Karimi-Busheri F, Zadorozhny V, Li T, Lin
H, Shawler DL and Fakhrai H: Pivotal role of CD38 biomarker in
combination with CD24, EpCAM, and ALDH for identification of H460
derived lung cancer stem cells. J Stem Cells. 6:9–20.
2011.PubMed/NCBI
|
|
7
|
Curley MD, Therrien VA, Cummings CL,
Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden
DT, Rueda BR and Foster R: CD133 expression defines a tumor
initiating cell population in primary human ovarian cancer. Stem
Cells. 27:2875–2883. 2009.PubMed/NCBI
|
|
8
|
Zimmerer RM, Korn P, Demougin P, Kampmann
A, Kokemüller H, Eckardt AM, Gellrich NC and Tavassol F: Functional
features of cancer stem cells in melanoma cell lines. Cancer Cell
Int. 13:782013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li C, Lee CJ and Simeone DM:
Identification of human pancreatic cancer stem cells. Methods Mol
Biol. 568:161–173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng D, Peng C, Li C, Zhou Y, Li M, Ling
B, Wei H and Tian Z: Identification and characterization of cancer
stem-like cells from primary carcinoma of the cervix uteri. Oncol
Rep. 22:1129–1134. 2009.PubMed/NCBI
|
|
11
|
Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ
and Maccallum J: In vivo investigation of CD133 as a putative
marker of cancer stem cells in Hep-2 cell line. Head Neck.
31:94–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhuang HW, Mo TT, Hou WJ, Xiong GX, Zhu
XL, Fu QL and Wen WP: Biological characteristics of CD133(+) cells
in nasopharyngeal carcinoma. Oncol Rep. 30:57–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oliveira LR, Castilho-Fernandes A,
Oliveira-Costa JP, Soares FA, Zucoloto S and Ribeiro-Silva A:
CD44+/CD133+ immunophenotype and matrix
metalloproteinase-9: Influence on prognosis in early-stage oral
squamous cell carcinoma. Head Neck. 36:1718–1726. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu W, Wu L, Shen XM, Shi LJ, Zhang CP, Xu
LQ and Zhou ZT: Expression patterns of cancer stem cell markers
ALDH1 and CD133 correlate with a high risk of malignant
transformation of oral leukoplakia. Int J Cancer. 132:868–874.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen C, Xiang M, Nie C, Hu H, Ma Y and Wu
H: CD44 as a molecular marker to screen cancer stem cells in
hypopharyngeal cancer. Acta Otolaryngol. 133:1219–1226. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YP, Wang MZ, Luo YR, Shen Y and Wei
ZX: Lentivirus-mediated shRNA interference targeting SLUG inhibits
lung cancer growth and metastasis. Asian Pac J Cancer Prev.
13:4947–4951. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin ZX: Patterns in the occurrence and
development of tumors. Chin Med J (Engl). 124:1097–1104.
2011.PubMed/NCBI
|
|
19
|
Miyoshi N, Ishii H, Sekimoto M, Haraguchi
N, Doki Y and Mori M: Properties and identification of cancer stem
cells: A changing insight into intractable cancer. Surg Today.
40:608–613. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Charafe-Jauffret E, Ginestier C, Iovino F,
Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra JM, Bertucci
F, Jacquemier J, et al: Aldehyde dehydrogenase 1-positive cancer
stem cells mediate metastasis and poor clinical outcome in
inflammatory breast cancer. Clin Cancer Res. 16:45–55. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koukourakis MI, Giatromanolaki A, Tsakmaki
V, Danielidis V and Sivridis E: Cancer stem cell phenotype relates
to radio-chemotherapy outcome in locally advanced squamous cell
head-neck cancer. Br J Cancer. 106:846–853. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hall SF, Groome PA, Irish J and O'Sullivan
B: The natural history of patients with squamous cell carcinoma of
the hypopharynx. Laryngoscope. 118:1362–1371. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fire A, Xu S, Montgomery MK, Kostas SA,
Driver SE and Mello CC: Potent and specific genetic interference by
double-stranded RNA in Caenorhabditis elegans. Nature. 391:806–811.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rubinson DA, Dillon CP, Kwiatkowski AV,
Sievers C, Yang L, Kopinja J, Rooney DL, Zhang M, Ihrig MM, McManus
MT, et al: A lentivirus-based system to functionally silence genes
in primary mammalian cells, stem cells and transgenic mice by RNA
interference. Nat Genet. 33:401–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liau SS, Ashley SW and Whang EE:
Lentivirus-mediated RNA interference of HMGA1 promotes
chemosensitivity to gemcitabine in pancreatic adenocarcinoma. J
Gastrointest Surg. 10:1254–1262. 2006.discussion 1263. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Couto LB and High KA: Viral
vector-mediated RNA interference. Curr Opin Pharmacol. 10:534–542.
2010. View Article : Google Scholar : PubMed/NCBI
|
